SUMMARY for Synergy Pharmaceuticals Inc., SGYP | Saturday, August 12, 2017
- The most active stocks on NASDAQ Stock Exchange
- Heavily traded shares in the exchange
- Level of Volume indicating an entry or exit situation
- P/E Ratio Analysis
- PEG Ratio Analysis
- How the company finances its assets; debt/equity
- EPS indicating company’s profitability
- Change in price rate
The most active shares in an exchange indicates that these shares are heavily bought and sold in today’s market. They often have a large number of shares outstanding. The rationale behind such high activity for a share could be their large number of shares outstanding or due to special situations such as there being a tender offer for the company and unexpected news.
Synergy Pharmaceuticals Inc., SGYP traded at a stock price of $2.98, exhibiting 15818939 shares in volume. -2.93% change in price for Synergy Pharmaceuticals Inc. indicates the momentum and velocity. For investors, a positive change in price indicates an upward buying pressure or positive momentum while a negative change in price designates a downward momentum for that stock.
For the most active stocks in the market, it is highly important to check the outstanding shares of the company. The outstanding shares for Synergy Pharmaceuticals Inc. is 222.55, along with a floating outstanding shares of 222.55. Outstanding shares denotes a company’s stock currently held by all its shareholders, comprising share blocks apprehended by institutional investors and limited shares owned by the officers and insiders of the organization. The amount of a company’s shares outstanding is not fixed, but may vary extensively over time.
Market capitalization of 663.2M shares for the company helps traders interpret the size of Synergy Pharmaceuticals Inc., acting as the basic determinant for numerous important characteristics that affects an investment decision.
The P/E ratio of *tba for Synergy Pharmaceuticals Inc., SGYP, provides an insight into the measurement sticks, which compares the company’s valuations. The PE ratio shows how the company is performing in its financial terms compared to its competitors. A lower P/E ratio costs less per share for the same level of performance than a company with a higher P/E ratio. As expected, an investor would want to pay less for the same degree of performance.
The PEG ratio for Synergy Pharmaceuticals Inc. is currently *tba. Looking deep into the PEG, the metric allows the investor to understand whether the company is undervalued or not, and whether it is growing or going down.
Knowing how the debt/equity ratio works helps understand buyers how a company finances its assets. It is significantly essential for any investor where the metric indicates what part of finance the firm has attained in debt and equity. Synergy Pharmaceuticals Inc., SGYP has a debt/equity of 0.16, and the LTdebt/equity (Long Term Debt/Equity) of 0.16.
As an investor, you would definitely want to know the profitability of a company and how it gains you money. This is where EPS comes in. Earnings per share (EPS) shows a trader what portion of a company’s profit is allocated to each outstanding share of common stock. Earnings per share acts as an indicator of a company’s profitability and is considered the single most essential variable in determining the share price of a company. -1.07 EPS for Synergy Pharmaceuticals Inc. shows how profitable the company is alongside the other key metrics such as volatility.
Volatility is a key metric to analyze the most active stocks in an exchange. Investors must be aware that the higher the volatility the riskier the stock is to trade with. The weekly volatility was 10.05% for Synergy Pharmaceuticals Inc., SGYP, making it easy for the traders to interpret how riskier their investment is on this stock. 5.59% was its monthly volatility for Synergy Pharmaceuticals Inc., SGYP.